Intervet Forms Companion Animal Business Team

Intervet Inc., which recently received approval for its canine diabetes treatment Vetsulin, has formed a new Companion Animal Business Team to support its expansion in this market.

Intervet Inc., which recently received approval for its canine diabetes treatment Vetsulin, has formed a new Companion Animal Business Team to support its expansion in this market.

"By having a focused team of professional sales, marketing and technical services representatives, Intervet is underscoring the importance of better serving U.S. companion animal veterinarians," said Dr. Sebastien Huron, director of the new team. "Intervet’s worldwide leadership and focused R&D initiatives provide a solid foundation for the delivery of new technologies designed to answer a variety of unmet medical needs of our pets."

Intervet, a division of Intervet International, reports it plans to have a presence at all major veterinary conventions in 2005, starting with the North American Veterinary Conference in Orlando in January.

<HOME>

Leave a Comment

Comments

Your email address will not be published. Required fields are marked *

Register

Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).
 

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.